Primoris Services Corporation Announces Utilities and Distribution Award Valued at $21 Million
May 15, 2017 11:31 am UTC| Business
DALLAS, May 15, 2017 -- Primoris Services Corporation (NASDAQ:PRIM)(“Primoris” or “Company”) today announced a new Master Service Agreement (“MSA”) with a major utility customer with a three-year anticipated value of...
Primoris Services Corporation Announces Utilities and Distribution Award Valued at $21 Million
May 15, 2017 11:31 am UTC| Business
DALLAS, May 15, 2017 -- Primoris Services Corporation (NASDAQ:PRIM)(“Primoris” or “Company”) today announced a new Master Service Agreement (“MSA”) with a major utility customer with a three-year anticipated value of...
May 15, 2017 11:31 am UTC| Business
BELLEVUE, Wash., May 15, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer, Mike Sievert, Chief Operating Officer, and Peter Ewens, Executive Vice President, Corporate Strategy of T-Mobile US,...
May 15, 2017 11:31 am UTC| Business
BELLEVUE, Wash., May 15, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer, Mike Sievert, Chief Operating Officer, and Peter Ewens, Executive Vice President, Corporate Strategy of T-Mobile US,...
KalVista Pharmaceuticals to Recognize HAE Day 2017
May 15, 2017 11:31 am UTC| Business
CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, May 15, 2017 -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
KalVista Pharmaceuticals to Recognize HAE Day 2017
May 15, 2017 11:31 am UTC| Business
CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, May 15, 2017 -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
VBL Therapeutics Announces First Quarter 2017 Financial Results
May 15, 2017 11:15 am UTC| Business
TEL AVIV, Israel, May 15, 2017 -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, announced...